Clinical Trial Update: Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma [Phase 1]

View source ↗

Summary

OncoPep, Inc. reports the completion of a Phase 1/2a cancer vaccine study for Smoldering Multiple Myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• OncoPep cancer vaccine

Snippet

Sponsor: OncoPep, Inc. | Conditions: Smoldering Multiple Myeloma | Phase 1 | Status: COMPLETED